Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Identifying brain biomarkers for cognitive rehabilitation in schizophrenia

Official title: Optimization of Neurophysiologic Biomarkers for Rehabilitation Interventions in Veterans With Chronic Psychosis

Run by VA Office of Research and Development · NCT05945602 · Data updated 2026-11-12

This study is trying to find brain markers that can help identify Veterans with schizophrenia who would benefit most from cognitive rehabilitation therapies.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment80 (estimated)
SponsorVA Office of Research and Development
Federal
Locations1 site (San Diego, California)
StatusRecruiting
StartedOctober 1, 2023
Main results expectedSeptember 30, 2028
Study endsSeptember 30, 2028
Registry record updatedOctober 9, 2025
Trial IDNCT05945602 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include Veterans diagnosed with schizophrenia or other chronic psychotic disorders, as well as healthy Veterans in good general health.

Probably not a fit

Patients with active substance use or significant medical or neurological illnesses may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop brain-based tools to identify Veterans with schizophrenia who are most likely to benefit from cognitive rehabilitation therapies. It involves comprehensive neurophysiological, clinical, cognitive, and functional assessments of Veterans diagnosed with schizophrenia and healthy controls at the VA San Diego Healthcare System. The study is conducted in two phases: the first phase focuses on optimizing neurophysiological biomarkers linked to brain function, while the second phase evaluates these biomarkers' sensitivity to cognitive training interventions. The ultimate goal is to enhance the effectiveness of cognitive remediation for improving daily functioning in Veterans with chronic psychosis.

Why it matters

Potential benefit: If successful, this study could lead to improved cognitive rehabilitation strategies for Veterans with schizophrenia, enhancing their daily functioning and quality of life.

How similar studies have gone: While cognitive remediation has shown some benefits in schizophrenia, this approach of using neurophysiological biomarkers for patient selection is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Have a DSM-5 diagnosis of a chronic psychotic disorder (e.g., schizophrenia, schizoaffective disorder, or delusional disorder); or b) are in good general mental and physical health (i.e., no active mental health condition).
2. Fluent in spoken and written English.
3. No impairment in hearing or vision.

Exclusion Criteria:

1. Active substance other than cannabis within the last 30 days as determined by self-report or positive urine toxicology (obtained as part of the screening process).
2. History of significant medical or neurological illness or intellectual disability.
3. Inability to comprehend or provide informed consent.
4. Specific to healthy comparison subjects: past or present diagnosis of schizophrenia, schizoaffective disorder, or other chronic psychotic disorder.

Where it's running

  • VA San Diego Healthcare System, San Diego, CA
    San Diego, California, United States
    Recruiting

Study contacts

  • Principal investigator: Juan Molina, MD — VA San Diego Healthcare System, San Diego, CA
  • Study coordinator: Juan Molina, MD
  • Email: Juan.Molina@va.gov
  • Phone: (202) 555-8975

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.